A network perspective on cognition in individuals with Parkinson's disease
- PMID: 39996032
- PMCID: PMC11848640
- DOI: 10.1002/dad2.70091
A network perspective on cognition in individuals with Parkinson's disease
Abstract
Introduction: In neuropsychological diagnostics, the assignment of cognitive tests to domains is usually not empirically based. Hence, we aimed to assess the dimensionality structure of cognition in individuals with Parkinson's disease (PD) and conceptually replicate the findings in cognitively healthy individuals (CHIs).
Methods: We performed Exploratory Graph Analysis (EGA) for dimensionality analysis of cognitive test scores in N = 698 individuals with PD from the DEMPARK/LANDSCAPE study. Redundancy was reduced based on Unique Variable Analysis (UVA) before re-performing EGA. CHI data (N = 60,398) served as a conceptual replication base.
Results: EGA identified five dimensions. After removing redundancy identified by UVA, EGA identified a unidimensional structure of cognitive test scores. The findings were conceptually replicated in CHIs.
Discussion: The findings imply the need to re-evaluate the composition of cognitive test batteries to reduce redundancy and improve the validity of cognitive diagnostics. Cognition may be better described as a network of interrelated cognitive functions rather than a factorial structure of latent cognitive domains.
Highlights: Cognitive test scores of the same paradigm were strongly associated with each other.This finding indicates redundancy in the cognitive test battery.After removing redundancy, scores were best represented by unidimensional structures.The findings in Parkinson's disease were conceptually replicated in healthy controls.The results suggest that cognition should be viewed as a complex "network" of interrelated functions.
Keywords: Parkinson's disease; cognitive decline; cognitive domains; dimensionality analysis; mutualism hypothesis; network analysis; network neuropsychology.
© 2025 The Author(s). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.
Conflict of interest statement
D.S., M.B.G., D.B., R.H.R., B.M., K.R., O.R., S.R., J.B.S., A.S., C.T., H.U.W., R.D., and A.O. have no competing interests to declare. E.K. received grants from the German Ministry of Education and Research, the Joint Federal Committee, and The German Parkinson Foundation, all outside the submitted work. E.K. received honoraria from the companies EISAI GmbH, Germany, memodio GmbH, Germany, Desitin GmbH, Germany, and Prolog GmbH, Germany, all outside the submitted work. J.K. is a consultant and speaker for AbbVie, Bial, Biogen, Desitin, Esteve, Novartis, Roche, STADA, UCB Pharma, and Zambon; in addition, he is Specialty Chief Editor for Frontiers in Neurology (section Applied Neuroimaging) and Associate Editor (Neurology) for Therapeutic Advances in Chronic Disease. I.L.S. reports funding from Bayer AG and travel grants from Desitin and the German Society for Neurology outside the submitted work. K.W. receives funding from the Deutsche Forschungsgemeinschaft (German Research Association) and STADAPHARM GmbH outside the present study. He has received honoraria for presentations/advisory boards/consultations from BIAL, Indorsia, Boston Scientific and STADAPHARM GmbH, outside the present study. He has received royalties from Thieme Press and Elsevier Press. He serves as an editorial board member of Wiley's Parkinson's Disease, Behavioural Neurology, and PLOS One. Author disclosures are available in the Supporting Information.
Figures


References
-
- Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease‐associated cognitive impairment. Nature Reviews Disease Primers. 2021;7(1):47. - PubMed
-
- Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021;397(10291):2284‐303. - PubMed
-
- Baiano C, Barone P, Trojano L, Santangelo G. Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: a meta‐analysis. Mov Disord. 2020;35(1):45‐54. - PubMed
-
- Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22(12):1689‐1707. - PubMed
LinkOut - more resources
Full Text Sources